KRAEMATON INVESTMENT ADVISORS, INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1910852
BRAINTREE, MA
Position in VRTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$302,011
+$30,515 QoQ
Shares Held
608
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#1,210
of 1,705 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KRAEMATON INVESTMENT ADVISORS, INC holds $1,381,886 across 2 Biotechnology names. VRTX ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OCUL |
Ocular Therapeutix, Inc
|
109,967 | $1,079,875 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
608 | $302,011 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $302,011 | 608 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $271,496 | 608 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $275,642 | 608 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $292,946 | 748 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $423,385 | 951 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $463,003 | 955 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $417,599 | 1,037 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $517,168 | 1,112 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $483,250 | 1,031 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $430,968 | 1,031 | Shares | Sole | 2024-05-03 | |
| 2022-12-31 | $94,431 | 327 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||